A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.

by Eric Fitzsimmons

CAR T-cell therapy effects continue 10 years after treatment and first T-cell receptor therapeutic approved for uveal melanoma.

by Eric Fitzsimmons

Pharmacies asked to stop turning immune-compromised people away for fourth shot, and fiber intake is associated with stronger immune response in people with melanoma.

by Marci A. Landsmann

Metastatic cancer patients nearing death continue to receive high-dose radiation despite guidelines advising against it, and new standards are likely to reduce racial disparities in lung cancer screening.

by Kevin McLaughlin

Cancer mortality continues to go down, and a “real-world” study finds more than a third of active surveillance patients are lost to follow-up.

by Eric Fitzsimmons

Three out of four people with advanced colorectal cancer suffer significant financial hardship, and lung cancer patients who quit smoking experience increased survival.

by Marci A. Landsmann

The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.

by Cancer Today Staff

Healthy Habits

A broad review of existing research finds eating more mushrooms is associated with lower risk of developing cancer.

by Ashley P. Taylor

From the Editor-in-Chief

Data analysis platforms that map the cosmos are being applied to map the tumor microenvironment, an approach that could revolutionize cancer pathology.

by William G. Nelson, MD, PhD

Forward Look

Researchers aim to minimize disease relapses by targeting multiple proteins.

by Erin O'Donnell